Medibio Limited Stock Price Patterns

MDBIF Stock  USD 0  0.00  0.00%   
As of 17th of February 2026 the relative strength index (rsi) of Medibio's share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Medibio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Medibio and does not consider all of the tangible or intangible factors available from Medibio's fundamental data. We analyze noise-free headlines and recent hype associated with Medibio Limited, which may create opportunities for some arbitrage if properly timed.
Using Medibio hype-based prediction, you can estimate the value of Medibio Limited from the perspective of Medibio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medibio to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Medibio because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Medibio after-hype prediction price

    
  USD 0.002585  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Medibio Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.00010.68
Details

Medibio After-Hype Price Density Analysis

As far as predicting the price of Medibio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medibio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Medibio, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Medibio Estimiated After-Hype Price Volatility

In the context of predicting Medibio's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medibio's historical news coverage. Medibio's after-hype downside and upside margins for the prediction period are 0.00 and 10.68, respectively. We have considered Medibio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0
0
After-hype Price
10.68
Upside
Medibio is out of control at this time. Analysis and calculation of next after-hype price of Medibio Limited is based on 3 months time horizon.

Medibio Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Medibio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medibio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medibio, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.36 
10.68
 0.00  
 0.00  
0 Events / Month
0 Events / Month
Uncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0
0
3.39 
0.00  
Notes

Medibio Hype Timeline

Medibio Limited is now traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medibio is forecasted to increase in value after the next headline, with the price projected to jump to 0.002585 or above. The average volatility of media hype impact on the company the price is insignificant. The price rise on the next news is estimated to be 3.39%, whereas the daily expected return is now at -1.36%. The volatility of related hype on Medibio is about 0.0%, with the expected price after the next announcement by competition of 0.00. Medibio Limited has accumulated 66.42 K in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Assuming the 90 days horizon the next forecasted press release will be uncertain.
Check out Medibio Basic Forecasting Models to cross-verify your projections.

Medibio Related Hype Analysis

Having access to credible news sources related to Medibio's direct competition is more important than ever and may enhance your ability to predict Medibio's future price movements. Getting to know how Medibio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medibio may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
UDOCFUnidoc Health Corp 0.00 0 per month 8.62  0  20.00 (18.75) 48.08 
SPLTFSpotLite360 Technologies 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
VYNDVynleads 0.00 0 per month 0.00  0.06  0.00  0.00  73.53 
OXBOFOxford BioDynamics Plc 0.00 0 per month 0.00  0.03  0.00  0.00  192.86 
FPCGFirst Physicians Capital 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TRUFFRed Light Holland 0.00 0 per month 0.00 (0.07) 16.67 (12.00) 38.00 
CMHSFComprehensive Healthcare Systems 0.00 0 per month 0.00 (0.18) 0.00  0.00  10.26 
AIMLFAIML Innovations 0.00 0 per month 6.17  0.02  12.34 (13.29) 35.98 
PAXHPreAxia Health Care 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
MMJJFMMJ Group Holdings 0.00 0 per month 0.00  0.11  0.00  0.00  11.58 

Medibio Additional Predictive Modules

Most predictive techniques to examine Medibio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medibio using various technical indicators. When you analyze Medibio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Medibio Predictive Indicators

The successful prediction of Medibio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medibio Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medibio based on analysis of Medibio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medibio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medibio's related companies.

Currently Active Assets on Macroaxis

Complementary Tools for Medibio Pink Sheet analysis

When running Medibio's price analysis, check to measure Medibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medibio is operating at the current time. Most of Medibio's value examination focuses on studying past and present price action to predict the probability of Medibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medibio's price. Additionally, you may evaluate how the addition of Medibio to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data